Klinische Forschung Gruppe Nord

What Klinische Forschung Gruppe Nord does

Klinische Forschung Gruppe Nord, now operating under the Pratia S.A. brand, is a German clinical research organization founded in 1993 that operates a network of six ambulatory clinical trial centers across Germany (Berlin, Dresden, Hamburg, Hannover, Karlsruhe, and Schwerin). The company provides site operations, central site services coordination, patient recruitment via its Patientenstudien.de platform (with 80,000+ registered patients), pre-feasibility and feasibility assessments, and quality management services for pharmaceutical and biotech sponsors. With approximately 80 employees and 700+ studies conducted over more than three decades, KFGN/Pratia positions itself as a multi-therapeutic-area site network covering indications such as gastroenterology, dermatology, cardiology, allergology, nephrology, internal medicine, chronic pain, and medical devices.

The company makes money through professional services fees paid by pharmaceutical sponsors for conducting clinical trials at its site network, with revenue derived from site operations, patient recruitment, feasibility studies, and project management. Its go-to-market is direct enterprise sales to pharmaceutical and biotech companies, using central coordination to provide sponsors with a single point of contact across all six centers. KFGN rebranded in March 2023 to align with the broader Pratia European site network identity, but the underlying German operating entity remains Pratia S.A., privately held with no disclosed institutional ownership or funding rounds.

The company's underlying platform combines physical trial infrastructure (six ambulatory centers), a network of specialist physicians and hospital connections enabling broad therapeutic coverage, and a proprietary patient recruitment database. Differentiators cited by the company include 30 years of experience, multi-site network flexibility, and the scale of its patient panel. Customer engagement is supported through the Patientenstudien.de self-service portal, a corporate news/blog channel, and participation in industry events such as International Clinical Trials Day.

Name

Klinische Forschung Gruppe Nord

Legal name

Pratia S.A.

Website

https://kfgn.de

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Klinische Forschung Gruppe Nord (operating as Pratia S.A.) is a German clinical research organization running a network of six ambulatory clinical trial centers, providing site operations, patient recruitment, and feasibility services to pharmaceutical and biotech sponsors across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Research Organization Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAKAI

Clinical Quality Assurance (GCP QA, TMF/QMS oversight)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Clinical trial services
• Patient recruitment
• Site management
• Clinical research organization
• Ambulatory trial centers

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Site Services: Service fees from pharmaceutical companies for conducting clinical trials at their site network. Includes site operations, patient recruitment, feasibility studies, quality management, and project coordination services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Klinische Forschung Gruppe Nord (operating as Pratia S.A.) operates a network of six ambulatory clinical trial centers across Germany, providing pharmaceutical sponsors with end-to-end clinical trial execution services including site operations, central project coordination, patient recruitment (via a database of 80,000+ registered individuals), feasibility assessments, and quality management. The company specializes in recruiting patients and conducting Phase I-IV clinical studies across therapeutic areas such as gastroenterology, dermatology, cardiology, and internal medicine.

Product overview

Pratia S.A. (formerly Klinische Forschung Gruppe Nord / kfgn) is a clinical research organization offering a comprehensive portfolio of services for clinical trials. The company operates a network of six ambulatory examination centers in Germany and provides integrated services including Site Operations (site management and network coordination), Site Services (central project management), Patient Recruitment (with access to a database of over 80,000 registered patients), Pre-Feasibility & Feasibility assessments, and Quality Management. Their specialty areas span gastroenterology, dermatology, cardiology, general medicine, allergology, medical devices, chronic pain, nephrology, and internal medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Site Operations Clinical trial site management service providing flexibility and network capability to cover any study indication through the company's structure of examination centers, specialist doctor, and clinic connections. For pharmaceutical sponsors conducting clinical trials.
• Site Services Central coordination of all services ensuring efficient project management for clinical studies, with single points of contact for all sites, partners, and clients at every project status. For pharmaceutical sponsors.
• Patient Recruitment (Patientenrekrutierung) Patient recruitment service for clinical trials using various media channels, supported by an annual database of thousands of new registrations on the Patientenstudien.de website. For pharmaceutical sponsors needing eligible patients for clinical studies.
• Pre-Feasibility & Feasibility Central coordination and organization of all feasibility inquiries through one contact person for all sites, enabling rapid and on-time assessment of project feasibility in various settings. For pharmaceutical sponsors evaluating trial feasibility.
• Quality Management (Qualitätsmanagement) Quality management service ensuring high implementation quality in compliance with all applicable guidelines and laws, forming the basis for generating high data quality in every clinical study. For pharmaceutical sponsors requiring regulatory-compliant clinical trial execution.
• Pratia Prüfzentren (Examination Centers) Ambulatory clinical trial centers located in Berlin, Dresden, Hamburg, Hannover, Karlsruhe, and Schwerin, providing physical sites for the conduct of clinical trials. For pharmaceutical sponsors requiring geographic site coverage in Germany.

Quantifiable outcome

• 80,000+ patients in database with thousands of new registrations annually

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• UNION TherapeuticscoreStrategic or Co-development Partner · 23 November 2021Collaboration for the PREVENT-COVID-19 treatment study evaluating niclosamide in COVID-19 patients. kfgn (now Pratia) enrolled the first patient in this clinical trial for UNION Therapeutics. This represents a strategic partnership in conducting clinical treatment studies for biotech/pharma companies.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-to-large global CRO with site operations across Europe. Competes for phase II–III ambulatory trial site contracts in Germany with a full-service clinical development model.
• Thermo Fisher Scientific (PPD): Acquired PPD to form one of the world's largest CROs with extensive site and patient recruitment infrastructure. Competes for German ambulatory trial site contracts as part of full-service clinical development.
• Syneos Health: Biopharma solutions organization with site management and patient recruitment offerings. Competes with KFGN for decentralized and hybrid trial site partnerships in Germany.
• ICON plc: Global CRO with dedicated site and patient recruitment capabilities (formerly PRA Health). Competes for ambulatory trial site partnerships with pharma sponsors across Europe.
• IQVIA: Largest global CRO and site network operator. Competes with KFGN for pharma-sponsored trial site services in Germany as part of a much broader full-service clinical development portfolio.

Direct peers

• Panthera Biopartners: UK-based SMO operating a network of clinical trial sites with strong patient recruitment capabilities. Directly comparable as a dedicated site network serving pharma-sponsored trials in Europe.
• KCR: Europe-headquartered CRO with strong site services and patient recruitment capabilities. Directly comparable as a regional clinical research services provider focused on European geographies.
• Flourish Research: US-based integrated SMO operating a multi-site ambulatory network focused on patient recruitment and trial execution. Closely comparable site-network model targeting pharma sponsors.
• Velocity Clinical Research: Dedicated integrated site organization (SMO) operating multiple ambulatory clinical trial centers. Directly comparable business model of multi-site network plus central patient recruitment for pharma sponsors.
• Pratia (broader European network): The broader European site network that KFGN rebranded into in March 2023. Operates ambulatory clinical trial centers across multiple European countries with the same patient recruitment and site services model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/kfgn-site-operations-and-services

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Klinische Forschung Gruppe Nord